Results 241 to 250 of about 27,000,079 (254)

Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial

Annals of Oncology, 2016
Claus Garbe, Dirk Schadendorf, C Pföhler   +2 more
exaly  

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy

Journal of Hepatology, 2001
Kirk Easley, W D Carey, Terry Gramlich
exaly  

Interferon-γ inhibits experimental renal fibrosis

Kidney International, 1999
A Meguid El Nahas, A M El Nahas
exaly  

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C

Journal of Hepatology, 2008
Leland J Yee, Charles D Howell, Milton W Taylor   +2 more
exaly  

Interferon

Ca-A Cancer Journal for Clinicians, 1972
exaly  

Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension

Circulation Research, 2014
Frédéric Perros, Eduardo Oliver, Daniel Reed   +2 more
exaly  

Interferon and Cancer Treatment

Ca-A Cancer Journal for Clinicians, 1978
exaly  

Sarcoidosis associated with interferon-α therapy for chronic hepatitis C

Journal of Hepatology, 1998
M C Jung, R Zachoval, Maria-Christina Jung   +2 more
exaly  

Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity

Cell, 2017
Xuetao Cao, Kun Chen, Dan Han
exaly  

In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, Whereas Interferon-α Sensitivity Is Unaltered

Journal of Investigative Dermatology, 2004
Jon Laman, Errol Prens
exaly